| Tretinoin | Approved Investigational Nutraceutical | MAP6D1 | 79929 |
upregulated | Tretinoin results in increased expression of MAP6D1 mRNA | 3q27.1 | |
| Tretinoin | Approved Investigational Nutraceutical | MAP7 | 9053 |
upregulated | Tretinoin results in increased expression of MAP7 mRNA | 6q23.3 | |
| Tretinoin | Approved Investigational Nutraceutical | MAPK10 | 5602 |
downregulated | Tretinoin results in decreased expression of MAPK10 mRNA | 4q21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | MAPK14 | 1432 |
downregulated | Tretinoin results in decreased expression of MAPK14 mRNA | 6p21.31 | |
| Tretinoin | Approved Investigational Nutraceutical | MAPK14 | 1432 |
upregulated | Tretinoin results in increased expression of MAPK14 mRNA | 6p21.31 | |
| Tretinoin | Approved Investigational Nutraceutical | MAPK1IP1L | 93487 |
upregulated | Tretinoin results in increased expression of MAPK1IP1L mRNA | 14q22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | MAPK4 | 5596 |
downregulated | Tretinoin results in decreased expression of MAPK4 mRNA | 18q21.1-q21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | MAPKAPK2 | 9261 |
upregulated | Tretinoin results in increased expression of MAPKAPK2 mRNA | 1q32.1 | |
| Tretinoin | Approved Investigational Nutraceutical | MAPKAPK5-AS1 | 51275 |
downregulated | Tretinoin results in decreased expression of MAPKAPK5-AS1 mRNA | 12q24.12 | |
| Tretinoin | Approved Investigational Nutraceutical | MAPT | 4137 |
upregulated | Tretinoin results in increased expression of MAPT mRNA | 17q21.31 | |
| Tretinoin | Approved Investigational Nutraceutical | MAPT | 4137 |
upregulated | Tretinoin results in increased expression of MAPT mRNA alternative form | 17q21.31 | |
| Tretinoin | Approved Investigational Nutraceutical | MARVELD2 | 153562 |
upregulated | Tretinoin results in increased expression of MARVELD2 mRNA | 5q13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | MARVELD3 | 91862 |
upregulated | Tretinoin results in increased expression of MARVELD3 mRNA | 16q22.2 | |
| Tretinoin | Approved Investigational Nutraceutical | MAST4 | 375449 |
upregulated | Tretinoin results in increased expression of MAST4 mRNA | 5q12.3 | |
| Tretinoin | Approved Investigational Nutraceutical | MAT2A | 4144 |
downregulated | Tretinoin results in decreased expression of MAT2A mRNA | 2p11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | MATN1 | 4146 |
upregulated | Tretinoin results in increased expression of MATN1 mRNA | 1p35.2 | |
| Tretinoin | Approved Investigational Nutraceutical | MATN2 | 4147 |
upregulated | Tretinoin results in increased expression of MATN2 mRNA | 8q22.1-q22.2 | |
| Tretinoin | Approved Investigational Nutraceutical | MATR3 | 9782 |
downregulated | Tretinoin results in decreased expression of MATR3 mRNA | 5q31.2 | |
| Tretinoin | Approved Investigational Nutraceutical | MAX | 4149 |
upregulated | Tretinoin results in increased expression of MAX mRNA | 14q23.3 | |
| Tretinoin | Approved Investigational Nutraceutical | MAZ | 4150 |
upregulated | Tretinoin results in increased expression of MAZ mRNA | 16p11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | MBD2 | 8932 |
upregulated | Tretinoin results in increased expression of MBD2 mRNA | 18q21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | MBNL1 | 4154 |
upregulated | Tretinoin results in increased expression of MBNL1 mRNA | 3q25.1-q25.2 | |
| Tretinoin | Approved Investigational Nutraceutical | MBNL2 | 10150 |
upregulated | Tretinoin results in increased expression of MBNL2 mRNA | 13q32.1 | |
| Tretinoin | Approved Investigational Nutraceutical | MBNL3 | 55796 |
downregulated | Tretinoin results in decreased expression of MBNL3 mRNA | Xq26.2 | |
| Tretinoin | Approved Investigational Nutraceutical | MBOAT1 | 154141 |
upregulated | Tretinoin results in increased expression of MBOAT1 mRNA | 6p22.3 | |